Canada markets close in 3 hours 5 minutes

Defence Therapeutics Inc. (DTC.CN)

Canadian Sec - Canadian Sec Real Time Price. Currency in CAD
Add to watchlist
6.300.00 (0.00%)
As of 10:41AM EDT. Market open.
Currency in CAD

Valuation Measures

Market Cap (intraday) 5N/A
Enterprise Value 3212.61M
Trailing P/E N/A
Forward P/E 1N/A
PEG Ratio (5 yr expected) 1N/A
Price/Sales (ttm)N/A
Price/Book (mrq)27.39
Enterprise Value/Revenue 3N/A
Enterprise Value/EBITDA 7N/A

Trading Information

Stock Price History

Beta (5Y Monthly) N/A
52-Week Change 3133.33%
S&P500 52-Week Change 332.68%
52 Week High 37.85
52 Week Low 32.56
50-Day Moving Average 36.85
200-Day Moving Average 35.73

Share Statistics

Avg Vol (3 month) 321.02k
Avg Vol (10 day) 37.99k
Shares Outstanding 5N/A
Implied Shares Outstanding 6N/A
Float 32.62M
% Held by Insiders 16.28%
% Held by Institutions 10.00%
Shares Short (Jun. 14, 2021) 414.69k
Short Ratio (Jun. 14, 2021) 40.51
Short % of Float (Jun. 14, 2021) 4N/A
Short % of Shares Outstanding (Jun. 14, 2021) 4N/A
Shares Short (prior month May 13, 2021) 4863

Dividends & Splits

Forward Annual Dividend Rate 4N/A
Forward Annual Dividend Yield 4N/A
Trailing Annual Dividend Rate 3N/A
Trailing Annual Dividend Yield 3N/A
5 Year Average Dividend Yield 4N/A
Payout Ratio 4N/A
Dividend Date 3N/A
Ex-Dividend Date 4N/A
Last Split Factor 2N/A
Last Split Date 3N/A

Financial Highlights

Fiscal Year

Fiscal Year Ends Jun. 29, 2020
Most Recent Quarter (mrq)Mar. 30, 2021

Profitability

Profit Margin 0.00%
Operating Margin (ttm)0.00%

Management Effectiveness

Return on Assets (ttm)N/A
Return on Equity (ttm)N/A

Income Statement

Revenue (ttm)N/A
Revenue Per Share (ttm)N/A
Quarterly Revenue Growth (yoy)N/A
Gross Profit (ttm)N/A
EBITDA N/A
Net Income Avi to Common (ttm)-1.65M
Diluted EPS (ttm)-0.09
Quarterly Earnings Growth (yoy)N/A

Balance Sheet

Total Cash (mrq)6.64M
Total Cash Per Share (mrq)0.19
Total Debt (mrq)N/A
Total Debt/Equity (mrq)N/A
Current Ratio (mrq)42.75
Book Value Per Share (mrq)0.23

Cash Flow Statement

Operating Cash Flow (ttm)-1.13M
Levered Free Cash Flow (ttm)N/A